IFNG and major depressive disorder: In a study by Fornaro et al. (2013), levels of cytokines, including IFN-γ, were monitored at baseline and at 6 and 12 weeks of treatment with duloxetine at the dose of 60 mg/day in patients with MDD (n = 30) and in controls (n = 32).